Pulse Biosciences, Inc.
NASDAQ:PLSE · NASDAQ Capital Market
+$0.97 today
Vol 0.36M · Avg 0.31M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+65.27%
Period High
$27.10
Period Low
$12.66
Latest
$25.60
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Dianthus Therapeutics, Inc.
NASDAQ:DNTH
$3.36B
NovoCure Limited
NASDAQ:NVCR
$1.69B
Atai Beckley Inc.
NASDAQ:ATAI
$1.49B
STAAR Surgical Company
NASDAQ:STAA
$1.43B
Immatics N.V.
NASDAQ:IMTX
$1.29B
Nektar Therapeutics
NASDAQ:NKTR
$1.17B
Kestra Medical Technologies, Ltd.
NASDAQ:KMTS
$1.12B
OPKO Health, Inc.
NASDAQ:OPK
$1.07B
Beta Bionics, Inc.
NASDAQ:BBNX
$609.16M
LifeMD, Inc.
NASDAQ:LFMD
$231.17M
What is the latest PLSE filing?
The latest filing shown is 4 dated Jun 15, 2026.
How many recent filings does PLSE have?
Intrinsic Alpha currently shows 20 recent filings for PLSE.
Explore More
Continue the stock analysis
Jump to another research area for this company.